I don't know what I want to do after university sos clindamycin phosphate review The widely praised deals will give Cubist, one of the fewbig players in U.S. antibiotics in the United States, anadditional $600 million to $1 billion in revenue on an annualbasis from the companies' lead drugs. Antibiotics has often beenshunned by many big pharma firms as a field of research due topoor returns.
Készíthetsz új témákat ebben a fórumban Válaszolhatsz egy témára ebben a fórumban Nem módosíthatod a hozzászólásaidat a fórumban Nem törölheted a hozzászólásaidat a fórumban Nem szavazhatsz ebben fórumban
